Fermion understands itself as a provider of different services, where the level and amount of service needs to be decided on a case by case. There is no general solution: What works in one case will not work in another. But what is the same from project to project is the number of components used in this approach:

• Offering partnering for in-licensing and co-marketing
• Contract manufacturing for dosage forms
• Contract manufacturing for small-scale APIs
• Being competitive in the API space by co-operating with partners for procuring early intermediates.

Fermion’s parent company, Orion Corporation, is able to offer contract manufacturing services for dosage forms in many different applications. The capabilities include tablets, capsules, solutions, sachets, creams/ointments as well as injections (vials and ampoules). Orion also has the unique capability to manufacture a dry powder inhaler device which has been commercialized so far with four different API’s (salbutamol, beclometasone, budesonide, and formoterol). The type of APIs which Orion is able to process stretches from oncology products to steroids and hormone products (including hormone-like substances).